(Q57435819)

9

0 references

Werner Maier

4

object named as

W. Maier

0 references

author name string

T. E. Schlaepfer

1

0 references

C. Frick

2

0 references

A. Zobel

3

0 references

I. Heuser

5

0 references

M. Bajbouj

6

0 references

V. O'Keane

7

0 references

C. Corcoran

8

0 references

M. Trimble

10

0 references

H. Rau

11

0 references

H.-J. Hoff

12

0 references

F. Padberg

13

0 references

F. Müller-Siecheneder

14

0 references

K. Audenaert

15

0 references

D. Van den Abbeele

16

0 references

D. Christmas

18

0 references

Z. Stanga

19

0 references

M. Hasdemir

Vagus nerve stimulation for seizures

20

0 references

language of work or name

English

0 references

publication date

4 January 2008

0 references

published in

Psychological Medicine

0 references

volume

38

0 references

issue

05

0 references

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Approving the vagus-nerve stimulator for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Cerebral blood flow changes during vagus nerve stimulation for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Vagus nerve stimulation therapy summary: five years after FDA approval

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

A review of functional neuroimaging studies of vagus nerve stimulation (VNS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Vagus nerve stimulation, side effects, and long-term safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Contemporary management of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Medication resistance and clinical response to electroconvulsive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Antidepressant treatments in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

The effects of antidepressants on the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

The medical management of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Mechanisms and state of the art of vagus nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Memory alterations during acute high-intensity vagus nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Head orientation and trajectory of locomotion during jumping and walking in domestic chicks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Vagus nerve stimulation: a new tool for brain research and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

Vagus nerve stimulation is associated with mood improvements in epilepsy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

7 January 2021

A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

7 January 2021

Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

7 January 2021

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

7 January 2021

Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

7 January 2021

Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

7 January 2021

Novel physical treatments for major depression: vagus nerve stimulation, transcranial magnetic stimulation and magnetic seizure therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

7 January 2021

A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation

1 reference

https://api.crossref.org/works/10.1017%2FS0033291707001924

7 January 2021